SCHEMBL6091085

SCHEMBL6091085

Cc1cc(C)cc(Cn2c(C(=O)O)c(-c3ccccc3)c3cc(-c4ccc(Cl)cc4)ccc32)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 10/20 0.57
PTGES O14684 5/20 0.57
SERPINE1 P05121 4/20 0.56
TBXAS1 P24557 2/20 0.50
EDNRB P24530 1/20 0.48
EDNRA P25101 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
ALOX12 P18054 1/20 0.48
PPARG P37231 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
HSD17B10 Q99714 1/20 0.48
AKR1B1 P15121 1/20 0.48
PTGDR2 Q9Y5Y4 1/20 0.48
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6092353 0.88 SERPINE1 (0.56) PTGES2PTGESSERPINE1TBXAS1EDNRB
SCHEMBL6093339 0.86 SERPINE1 (0.61) PTGES2PTGESSERPINE1EDNRBEDNRA
SCHEMBL14117729 0.84 SERPINE1 (0.56) SERPINE1EDNRBEDNRAMEN1KMT2A
SCHEMBL14117727 0.77 PTGDR2 (0.53) PTGES2PTGESSERPINE1EDNRBEDNRA
SCHEMBL27605863 0.76 PTGDR2 (0.72) PTGES2PTGESAKR1B1PTGDR2
SCHEMBL6093097 0.76 SERPINE1 (0.51) PTGES2PTGESSERPINE1TBXAS1PPARG
SCHEMBL6092255 0.76 ICMT (0.48) PTGES2PTGESSERPINE1TBXAS1PPARG
SCHEMBL4980145 0.76 SERPINE1 (0.81) SERPINE1EDNRBEDNRAMEN1KMT2A
SCHEMBL21465578 0.75 PTGES2 (0.53) PTGES2PTGESSERPINE1TBXAS1MEN1
SCHEMBL5172732 0.75 SERPINE1 (0.60) SERPINE1EDNRBEDNRAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 PTGES2 6/4885PTGES 4/4885SERPINE1 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.